Skip to main content

Table 3 ACTā€  prescription according to tests results, and clinical malaria* in pre- and post-RDT implementation areas

From: Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests

Ā 

Ifakara HDSS (pre- RDT implementation)

Rufiji HDSS (post- RDT implementation)

P-value

Ā 

n/N

%(95% CI)

n/N

%(95% CI)

Ā 

RDT positive

22/30

73.3 (53.1-87.0)

79/95

83.2 (69.2-91.6)

0.32

RDT negative

28/104

26.9 (16.4-40.9)

17/217

7.8 (4.7-12.7)

<0.01

Microscopy positive

62/110

56.4 (41.5-70.1)

15/36

41.7 (22.1-64.3)

0.28

Microscopy negative

7/135

5.2 (2.1-12.1)

5/96

5.2 (2.3-11.6)

0.99

Clinical diagnosis of malaria and no diagnostic test performed

165/313

52.7 (42.9-62.4)

99/220

45.0 (34.3-56.2)

0.33

No clinical diagnosis of malaria and no diagnostic test performed

7/94

7.5 (2.9-15.8)

2/49

4.1 (1.1-14.4)

0.45

  1. * Clinical diagnosis of malaria based on presence of fever in patients who did not receive a malaria diagnostic test ā€ ā€‰=ā€‰Artemether lumefantrine.